NXO

Calprotectin, Fecal

Product code
NXO
Device name
Calprotectin, Fecal
Device class
Class 2
21 CFR
21 CFR 866.5180
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
15 (all years; only the last 3 years are listed here)

FDA classification definition

The device is used for the measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The device can be used as an aid in the diagnosis of inflammatory bowel disease (ibd), crohn's disease and ulcerative colitis and to differentiate ibd from irritable bowel syndrome.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2024-02-06.

NumberDecision dateApplicantDevice nameSummary
K2320572024-02-06Bühlmann Laboratories AGBÜHLMANN fCAL® turbo and CALEX® CapPDF

1 summaries are archived here for direct download.

Official FDA classification page: NXO
Classification and pathway per current FDA publications. Data from openFDA (CC0).